Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides dates and types of meetings. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content. The document is essentially an announcement of upcoming investor meetings, not a report or transcript. Given the content and length (1405 characters), it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-29 English
General Updates
Regulatory Filings
2025-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, but does not contain any financial data, results, or detailed presentations. The document is brief (1334 characters) and serves as an announcement of upcoming meetings rather than the meetings' content or financial reports. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, but does not contain any financial data, detailed presentations, or reports. It is an announcement of upcoming meetings rather than the meetings' content or transcripts. The document length is only 1334 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a conference call held on May 14, 2025, discussing the audited financial results for the quarter and year ended March 31, 2025. It includes management commentary, financial performance data, segment-wise analysis, and a Q&A session with analysts. The presence of a full transcript of the earnings call, including forward-looking statements and detailed financial discussion, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content beyond a mere announcement or summary, ruling out categories like Earnings Release (ER) or Report Publication Announcement (RPA). The mention of the conference call, management speakers, and Q&A confirms the classification as a Call Transcript.
2025-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about a scheduled Analyst / Institutional Investor Meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, detailed presentation, or report. The document is brief (1245 characters) and serves as an announcement of an upcoming meeting rather than the meeting materials or transcript itself. Therefore, it fits best under the category of Investor Presentation announcements or meeting notifications. However, since it only informs about the schedule and does not provide the presentation itself, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations.
2025-05-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.